Food and Drug Administration Simple Reauthorization Act of 2022

S. 4535 · 117th Congress · Jul 14, 2022 · Lineage

A BILL

To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.

1. Short title; table of contents

(a)

Short title— This Act may be cited as the “Food and Drug Administration Simple Reauthorization Act of 2022” or the “FDASRA Act of 2022”.

(b)

Table of contents— The table of contents for this Act is as follows:

Food and Drug Administration Simple Reauthorization Act of 2022

1. Short title; table of contents

Cite this provision

Incoming references